Hirawat Samit, EVP and Chief Medical Officer for Drug Development, made one open market purchase of Bristol Myers Squibb ($BMY) shares in the last year, totaling $202,215. His latest buy occurred on April 25, 2025. Among 4,983 insiders, his purchase volume ranks 1,530th, well below the average of $1.5 million over 3.3 transactions. Samit reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 27, 2026 | Pacira BioSciences, Inc. | $PCRX | Hirawat Samit | Director | A | Stock Option (Right to Buy) | 39291 | $0.00 | 39,291.0000 | 45,729,000 | 9999.99% | 0.09% |
| April 25, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | Common Stock, $0.10 par value | 4250 | $47.58 | 83,513.4860 | 2,027,000,000 | 5.36% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4765 | $0.00 | 70,919.4860 | 2,027,000,000 | 7.20% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 831 | $0.00 | 70,088.4860 | 2,027,000,000 | 1.17% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2013 | $63.11 | 68,075.4860 | 2,027,000,000 | 2.87% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 5854 | $0.00 | 73,929.4860 | 2,027,000,000 | 8.60% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 998 | $0.00 | 72,931.4860 | 2,027,000,000 | 1.35% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2484 | $63.11 | 70,447.4860 | 2,027,000,000 | 3.41% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 28593 | $0.00 | 99,040.4860 | 2,027,000,000 | 40.59% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 10545 | $0.00 | 88,495.4860 | 2,027,000,000 | 10.65% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 9232 | $63.11 | 79,263.4860 | 2,027,000,000 | 10.43% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4886 | $0.00 | 0.0000 | 2,027,000,000 | 100.00% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4765 | $0.00 | 4,767.0000 | 2,027,000,000 | 49.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 5854 | $0.00 | 11,711.0000 | 2,027,000,000 | 33.33% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Market Share Units | 35146 | $0.00 | 35,146.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Performance Shares | 28593 | $0.00 | 0.0000 | 2,027,000,000 | 100.00% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Performance Shares | 52720 | $0.00 | 52,720.0000 | 2,027,000,000 | 9999.99% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4886 | $0.00 | 68,818.4860 | 2,027,000,000 | 7.64% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2327 | $63.11 | 66,154.4860 | 2,027,000,000 | 3.40% | 0.00% |
| March 10, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 337 | $0.00 | 68,481.4860 | 2,027,000,000 | 0.49% | 0.00% |
| Feb. 14, 2025 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | Common Stock, $0.10 par value | 1823 | $54.84 | 63,932.4860 | 2,027,000,000 | 2.94% | 0.00% |
| Nov. 1, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | P | Common Stock, $0.10 par value | 1830 | $54.68 | 62,109.0000 | 2,031,000,000 | 3.04% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Performance Shares | 60952 | $0.00 | 60,952.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4192 | $0.00 | 51,437.0000 | 2,078,000,000 | 8.87% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 660 | $0.00 | 50,777.0000 | 2,078,000,000 | 1.28% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 1807 | $53.79 | 48,970.0000 | 2,078,000,000 | 3.56% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4885 | $0.00 | 53,855.0000 | 2,078,000,000 | 9.98% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 842 | $0.00 | 53,013.0000 | 2,078,000,000 | 1.56% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2068 | $53.79 | 50,945.0000 | 2,078,000,000 | 3.90% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 29311 | $0.00 | 80,256.0000 | 2,078,000,000 | 57.53% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 10203 | $0.00 | 70,053.0000 | 2,078,000,000 | 12.71% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 9774 | $53.79 | 60,279.0000 | 2,078,000,000 | 13.95% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4192 | $0.00 | 0.0000 | 2,078,000,000 | 100.00% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4885 | $0.00 | 4,886.0000 | 2,078,000,000 | 49.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Market Share Units | 4765 | $0.00 | 9,532.0000 | 2,078,000,000 | 33.33% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Market Share Units | 5854 | $0.00 | 17,565.0000 | 2,078,000,000 | 25.00% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Market Share Units | 40635 | $0.00 | 40,635.0000 | 2,078,000,000 | 9999.99% | 0.00% |
| March 10, 2024 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Performance Shares | 29311 | $0.00 | 0.0000 | 2,078,000,000 | 100.00% | 0.00% |
| July 1, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 4787 | $63.95 | 47,245.0000 | 2,146,000,000 | 9.20% | 0.00% |
| July 1, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Restricted Stock Units | 9357 | $0.00 | 0.0000 | 2,146,000,000 | 100.00% | 0.00% |
| July 1, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 9357 | $0.00 | 52,032.0000 | 2,146,000,000 | 21.93% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 775 | $0.00 | 26,256.0000 | 2,146,000,000 | 3.04% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2540 | $65.71 | 23,716.0000 | 2,146,000,000 | 9.67% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4885 | $0.00 | 28,601.0000 | 2,146,000,000 | 20.60% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 802 | $0.00 | 29,403.0000 | 2,146,000,000 | 2.80% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2909 | $65.71 | 26,494.0000 | 2,146,000,000 | 9.89% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4765 | $0.00 | 31,259.0000 | 2,146,000,000 | 17.99% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 154 | $0.00 | 31,413.0000 | 2,146,000,000 | 0.49% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 2517 | $65.71 | 28,896.0000 | 2,146,000,000 | 8.01% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 25139 | $0.00 | 54,035.0000 | 2,146,000,000 | 87.00% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | J | Common Stock, $0.10 par value | 3069 | $0.00 | 57,104.0000 | 2,146,000,000 | 5.68% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | F | Common Stock, $0.10 par value | 14429 | $65.71 | 42,675.0000 | 2,146,000,000 | 25.27% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4189 | $0.00 | 4,192.0000 | 2,146,000,000 | 49.98% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4885 | $0.00 | 9,771.0000 | 2,146,000,000 | 33.33% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Market Share Units | 4765 | $0.00 | 14,297.0000 | 2,146,000,000 | 25.00% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Market Share Units | 23419 | $0.00 | 23,419.0000 | 2,146,000,000 | 9999.99% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Performance Shares | 25139 | $0.00 | 0.0000 | 2,146,000,000 | 100.00% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | A | Performance Shares | 35129 | $0.00 | 35,129.0000 | 2,146,000,000 | 9999.99% | 0.00% |
| March 10, 2023 | BRISTOL MYERS SQUIBB CO | $BMY | Hirawat Samit | EVP,Chief Med.Offr.,Drug Dev. | M | Common Stock, $0.10 par value | 4189 | $0.00 | 25,481.0000 | 2,146,000,000 | 19.67% | 0.00% |